US based Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, has announ...
The recently-closed CPhI Korea – co-organised by Informa Markets and the Korea Pharmaceutical Traders As...
LIPAC Oncology LLC and Huons Co., Ltd have announced that they have entered into an exclusive licensing agreement to dev...
Asia-Pacific specialist CRO Novotech has welcomed the South Korean Comprehensive Five-year Plan for the Advancement of C...
Korean firm Samsung Bioepis Co., Ltd. has announced its expansion into the Brazilian biopharmaceutical market. The first...
KT Corp. said its Global Epidemic Prevention Platform (GEPP) began service in Lao PDR on September 6 to help t...
The Korea Ginseng Association introduced new evidence of Korean Ginseng's efficacy on bone health. Korean Gins...
WONTECH, a leading Korean medical device company, has announced that its Holmium laser device, Holinwon Prima, received ...
ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companies, and DuChemB...
-Agilent Technologies has announced that Professor Hyun Joo An has received an Agilent Thought Leader Award in support o...
Voronoi, drug discovery and development biotech company in Korea has announced that it has, after an extensive evaluatio...
Gencurix, Inc., a molecular diagnostics company, announced the publication of a new study on Frontiers in Oncology&...
Centrient Pharmaceuticals, a global leader in sustainable antibiotics manufacturing, in partnership with Indian Institut...
Researchers at Seoul National University Hospital have found that non-vitamin K oral anticoagulant (NOAC) is effective i...
The International Diabetes Federation (IDF) Congress is bringing together the global diabetes community to tackle a broa...
KT Corp. said its Global Epidemic Prevention Platform (GEPP) started service in Ghana on 14th, the first such ...
Headquartered in Switzerland, The Straumann Group has entered into a partnership with Yuhan Corporation, Korea’s l...
Samsung BioLogics (SBL) has successfully performed N-1 (3,000L) perfusion with Alternating Tangential Flow (ATF) device ...
